AmbioPharm Employees: Headcount, Roles, and What They Do

AmbioPharm employs several hundred people, and most of them work at the company's peptide manufacturing campus in North Augusta, South Carolina. The workforce is built around process chemists, analytical chemists, quality-control analysts, engineers, and production operators who make peptide active ingredients for pharmaceutical and biotech clients. AmbioPharm does not publish a live headcount, so most public estimates come from company statements, industry reporting, and professional profiles.

How Many Employees Does AmbioPharm Have?

Publicly available figures put AmbioPharm's headcount in the several-hundred range, with most estimates clustering between roughly 300 and 400 people. That number has grown as the North Augusta campus expanded its GMP manufacturing capacity.

A few caveats matter. Headcount at private contract manufacturers changes quickly, and AmbioPharm has not released an audited, up-to-date employee count. Treat any specific number you see online as an estimate rather than a verified total.

Function	Typical roles	What the work involves
Process chemistry	Research and process development chemists	Designing and scaling solid-phase and solution-phase peptide synthesis
Analytical and QC labs	Analytical chemists, QC analysts	Running HPLC, mass spectrometry, and purity testing on batches
Quality and regulatory	QA specialists, validation and compliance staff	Reviewing batch records, deviations, and filings
Manufacturing	Operators and technicians	Running reactors, purification skids, and lyophilizers in clean suites
Engineering and support	Process, automation, and facilities engineers; supply chain and business staff	Keeping equipment qualified and client programs moving

What Kinds of Jobs Does AmbioPharm Hire For?

Day-to-day work centers on ambiopharm peptides, meaning the custom synthesis of peptide active pharmaceutical ingredients under GMP conditions. That shapes the roles the company recruits for.

• Process chemists who develop scalable synthesis routes and tech-transfer them into production.
• Analytical chemists who validate methods and test identity, purity, and stability.
• Quality assurance and quality control specialists who own documentation, investigations, and audits.
• Manufacturing operators who run synthesis, purification, and lyophilization equipment.
• Engineers in process, automation, and facilities roles.
• Regulatory, supply chain, and business development staff who support client programs.

Most of these positions are on-site. A chemist running a synthesis train or an operator loading a lyophilizer cannot do that work from a home office, which is why remote roles are concentrated in commercial and corporate functions.

Ownership and What Changed for Employees

CordenPharma acquired AmbioPharm in late 2022. The business now operates as CordenPharma AmbioPharm, part of the CordenPharma network and its parent group, International Chemical Investors Group.

For employees, the practical effects have been integration into a larger CDMO network, shared quality systems, and more cross-site project work. AmbioPharm is also one of the larger peptide companies in the United States that focuses almost entirely on contract manufacturing rather than branded drug sales. Staff work on client molecules, not on a single in-house product.

Where AmbioPharm Employees Work

AmbioPharm's staff footprint follows its ambiopharm locations, which center on the North Augusta, South Carolina campus where manufacturing, quality, and process development sit. Commercial, business development, and some corporate roles are based remotely or near client hubs.

Because the work involves controlled manufacturing suites and GMP documentation, production, quality, and lab roles stay on-site. That also means hiring tends to follow capacity expansions rather than seasonal demand.

Why People Search for "AmbioPharm Employees"

Most searches fall into one of three buckets, and each has a different answer.

1. Job seekers want to know whether the company is growing, what skills it hires for, and how the site is run.
2. Procurement and due-diligence teams want to confirm a supplier has enough trained staff to deliver a program on schedule.
3. Consumers run into the name while searching for peptides and assume it is a retail seller.

The third group is where misunderstandings happen. AmbioPharm is a business-to-business contract manufacturer, not a storefront.

AmbioPharm Employees Do Not Sell Peptides to Consumers

AmbioPharm manufactures peptide APIs for pharmaceutical, biotech, and research clients under contract. It does not run a consumer storefront, and there is no authorized consumer channel for the company's peptides.

Websites that advertise peptides "for sale" using a legitimate manufacturer's name are usually reselling research-grade material from an unrelated supplier or mislabeling a product entirely. Buyers who cannot get a domestic quote sometimes search for the best chinese peptide company instead, but the same diligence rules apply regardless of geography.

In the United States, most peptides sold for human use without a prescription are not FDA-approved, and their purity and identity are not independently verified.

Anyone considering a peptide for a health reason should talk with a healthcare professional first. A manufacturer's employee count says nothing about whether a product is safe or legal for personal use.

How to Verify What You Read About the Company

• Check the company's own site and its parent company's site for current facility and capability statements.
• Cross-reference large headcount claims against LinkedIn employee ranges and coverage in trade press.
• Ask a supplier for batch documentation and a certificate of analysis instead of trusting a brand name.

Company announcements typically focus on capacity additions, new equipment, and client programs rather than retail products, which is consistent with a CDMO business model.

Key Facts at a Glance

Item	Detail
Company type	Peptide contract development and manufacturing organization (CDMO)
Headquarters and main site	North Augusta, South Carolina, United States
Parent company	CordenPharma, which acquired AmbioPharm in late 2022
Estimated headcount	Several hundred; commonly cited in the 300 to 400 range
Main job functions	Process chemistry, analytical chemistry, QC/QA, manufacturing operations, engineering, regulatory, business support
Retail sales to consumers	None

COMMON QUESTIONS

Frequently Asked Questions

How many employees does AmbioPharm have?

AmbioPharm's headcount is generally reported in the several-hundred range, with most estimates falling between roughly 300 and 400 people. The company does not publish a verified, real-time employee count, so figures found online should be treated as estimates tied to a specific date.

Who owns AmbioPharm now?

CordenPharma acquired AmbioPharm in late 2022, and the business now operates as CordenPharma AmbioPharm. CordenPharma is part of International Chemical Investors Group, which gives the North Augusta site access to a larger multi-site manufacturing network.

Does AmbioPharm sell peptides directly to consumers?

No. AmbioPharm is a business-to-business peptide CDMO that manufactures active pharmaceutical ingredients for pharmaceutical, biotech, and research clients under contract. It does not operate a consumer storefront, so any website claiming to sell authentic AmbioPharm peptides to individuals is not an authorized retail channel.